Skip to main content
Clinical Trials/NCT06460571
NCT06460571
Recruiting
Not Applicable

The Effect of Cardiac Rehabilitation With and Without Delorme Technique of Progressive Resisted Exercises to Improve Dyspnea and Quality of Life in Patients of Post PCI.

Riphah International University1 site in 1 country52 target enrollmentJanuary 15, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Percutaneous CORONARY INTERVENTION
Sponsor
Riphah International University
Enrollment
52
Locations
1
Primary Endpoint
QUALITY OF LIFE SCALE:
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

To find the effect of cardiac rehabilitation program with and without progressive resisted exercises on patients after acute stage of PCI with at least 8 weeks history. It is a randomized clinical trial using convenient sampling technique. Randomly assign participants into two groups: An intervention group receiving Delorme progressive resisted exercise along with cardiac rehab and a control group undergoing standard cardiac rehabilitation alone. In Group A, Delorme technique will involve a 10-repetition max of aerobic and resistance exercises along with cardiac rehab. Seven different exercises will be performed in 3 sets of 10-repetition max. The control group will not be performing any type of training but will undergo cardiac rehab alone. Data will be analyzed using t test and SPSS 21 will be used for data collection. Age group will be from ≥70 years with patient undergoing dyspnea along with recent history of primary diseases. Data will be collected from Bethania Hospital, Sialkot through tools like the 6-minute walk test, Rose Angina questionnaire or settle angina questionnaire, quality of life scale (QOLFS), and Modified Borg dyspnea scale.

Registry
clinicaltrials.gov
Start Date
January 15, 2024
End Date
July 15, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age: ≥ 70 years"
  • "Recent history of PCI due to primary diseases (coronary heart disease, acute myocardial infarction, acute coronary syndrome, acute angina)"
  • "Presence of dyspnea"
  • "First-time PCI

Exclusion Criteria

  • "Renal failure"
  • Chronic liver disease
  • Chest disease
  • Patient who could not fulfill the questionnaire or cooperate through the performed procedures

Outcomes

Primary Outcomes

QUALITY OF LIFE SCALE:

Time Frame: baseline and fourth week

"The QOLS was originally a 15-item instrument that measured five conceptual domains of quality of life: material and physical well-being, relationships with other people, social, community and civic activities, personal development and fulfillment, and recreation

MODIFIED BORG DYSPNEA SCALE

Time Frame: baseline and fourth week

The Modified Borg Dyspnea Scale (MBS) is a numerical rating system (0-10) assessing dyspnea during submaximal exercise. Administered with the six-minute walk test (6MWT), a common measure for pulmonary arterial hypertension (PAH), the MBS is consistent within a single session

SETTLE ANGINA QUESTIONNAIRE

Time Frame: baseline and fourth week

Settle Angina Questionnaire (SAQ) scale is a disease specific scale is a diabetes specific scale for assessing QOL of CHD patients; have 5 items covering domains; Physical Limitation, Angina Stability, Angina Severity, Treatment Satisfaction and Disease Perception

Study Sites (1)

Loading locations...

Similar Trials